Skip to main content

Central Trust Co

SEC CIK
0000044365
Latest filing
Jul 31, 2026

LGND holding history

Ligand Pharmaceuticals Inc in every 13F filed by Central Trust Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LGND overviewAll 13F holders of LGNDFull Q2 2026 holdings

Shares (Q2 2026)
174
Value
$55.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of LGND by Central Trust Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026174$55.0K<0.1%+62+55.4%AddedHolders
Q1 2026112$22.4K<0.1%00.0%UnchangedHolders
Q4 2025112$21.2K<0.1%+8+7.7%AddedHolders
Q3 2025104$18.4K<0.1%−62−37.3%ReducedHolders
Q2 2025166$18.9K<0.1%00.0%UnchangedHolders
Q1 2025166$17.5K<0.1%00.0%UnchangedHolders
Q4 2024166$17.8K<0.1%+131+374.3%AddedHolders
Q3 202435$3.50K<0.1%00.0%UnchangedHolders
Q2 202435$2.95K<0.1%00.0%UnchangedHolders
Q1 202435$2.56K<0.1%00.0%UnchangedHolders
Q4 202335$2.50K<0.1%00.0%UnchangedHolders
Q3 202335$2.10K<0.1%00.0%UnchangedHolders
Q2 202335$2.52K<0.1%00.0%UnchangedHolders
Q1 202335$2.58K<0.1%00.0%UnchangedHolders
Q4 202235$2.34K<0.1%00.0%UnchangedHolders
Q3 202235$3.00K<0.1%00.0%UnchangedHolders
Q2 202235$3.00K<0.1%00.0%UnchangedHolders
Q1 202235$4.00K<0.1%00.0%UnchangedHolders
Q4 202135$5.00K<0.1%00.0%UnchangedHolders
Q3 202135$5.00K<0.1%00.0%UnchangedHolders
Q2 202135$5.00K<0.1%00.0%UnchangedHolders
Q1 202135$5.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.